Here are five articles published by Becker's Hospital Review in the past week that highlight a device recall, one hospital's supply chain makeover and a viewpoint piece on the dangers of a deregulated Food and Drug Administration, among other topics.
1. Bloomberg: Medtronic arranging sale of medical supplies business
Minneapolis-based Medtronic is preparing to sell part or all of its medical supplies business, an unnamed source told Bloomberg.
2. Trump, pharma CEOs discuss drug costs: 6 takeaways
President Donald Trump on Tuesday met with several pharmaceutical executives to discuss drug pricing and the state of the industry.
3. How one hospital made simple changes and trimmed supply costs by 2%
Three years ago, Caldwell Memorial Hospital partnered with Simpler Consulting to replace the hospital's transactional approach to supply chain with a strategic methodology for inventory management.
4. Mayo Clinic physician: A stripped down FDA would be 'chaotic'
STAT spoke with pharmaceutical insiders, physicians, Wall Street analysts and FDA veterans about the potential benefits and consequences of President Donald Trump's plan to deregulate the FDA and speed up the approval process for drugs and devices.
5. Bard Peripheral Vascular recalls Halo One guiding sheath
Bard Peripheral Vascular issued a voluntary recall of its Halo One Thin-Walled Guiding Sheath over structural issues with the device.
More articles on supply chain:
Shifting drug production back to US could raise prices: 5 takeaways
5 ways to prepare your supply chain for a disaster
Mayo Clinic physician: A stripped down FDA would be 'chaotic'